- Home
- SUNE vs ATNF Comparison
SUNE vs ATNF Comparison
Compare SUNE & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUNE
- ATNF
- Stock Information
- Founded
- SUNE 1969
- ATNF 2016
- Country
- SUNE United States
- ATNF United States
- Employees
- SUNE N/A
- ATNF N/A
- Industry
- SUNE
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- SUNE
- ATNF Health Care
- Exchange
- SUNE NYSE
- ATNF Nasdaq
- Market Cap
- SUNE 4.9M
- ATNF 4.1M
- IPO Year
- SUNE N/A
- ATNF N/A
- Fundamental
- Price
- SUNE $0.34
- ATNF $1.13
- Analyst Decision
- SUNE
- ATNF
- Analyst Count
- SUNE 0
- ATNF 0
- Target Price
- SUNE N/A
- ATNF N/A
- AVG Volume (30 Days)
- SUNE 31.4M
- ATNF 75.5K
- Earning Date
- SUNE 05-14-2018
- ATNF 03-18-2025
- Dividend Yield
- SUNE N/A
- ATNF N/A
- EPS Growth
- SUNE N/A
- ATNF N/A
- EPS
- SUNE N/A
- ATNF N/A
- Revenue
- SUNE $60,929,299.00
- ATNF N/A
- Revenue This Year
- SUNE $12.33
- ATNF N/A
- Revenue Next Year
- SUNE N/A
- ATNF $54.15
- P/E Ratio
- SUNE N/A
- ATNF N/A
- Revenue Growth
- SUNE N/A
- ATNF N/A
- 52 Week Low
- SUNE $0.16
- ATNF $1.07
- 52 Week High
- SUNE $315.00
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- SUNE N/A
- ATNF 36.24
- Support Level
- SUNE N/A
- ATNF $1.31
- Resistance Level
- SUNE N/A
- ATNF $1.20
- Average True Range (ATR)
- SUNE 0.00
- ATNF 0.10
- MACD
- SUNE 0.00
- ATNF 0.01
- Stochastic Oscillator
- SUNE 0.00
- ATNF 18.92
About SUNE SUNATION ENERGY INC
SUNation Energy Inc formerly Pineapple Energy Inc provides households with sustainable solar energy, back-up power and security, control and predictability, and cost savings. The company provides a full range of installation services, including the design, engineering, procurement, permitting, construction, grid connection, warranty, monitoring and maintenance of residential solar energy systems. It also offers battery storage to customers in select markets and serves a limited number of enterprise customers.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.